Signify Premium Insight: Lessons from a Unicorn: An Assessment of HeartFlow’s Ambition and Execution

Written by Alan Stoddart

Published: July 22, 2021

HeartFlow has served as something of a posterchild for many medical imaging AI vendors. Not only has it raised more funding than any other AI developer, its solution is reimbursed, and it has achieved a level of penetration that would be the envy of almost any other AI specialists. Further adding to this list of accolades is the news that HeartFlow is set to be acquired by a special purchase acquisition company (SPAC) facilitating its listing on the New York Stock Exchange. In going public,

 

Already have an account? Sign in here

Related Report

Machine Learning in Medical Imaging

Published June 2021

Machine Learning in Medical Imaging

This report is the 4th edition of our highly detailed, data-centric analysis of the world market for AI-based image analysis tools. An essential business planning tool to understand the current status and projected development of the market.  

Find out more